4 Topic Commentaries

Doing More With Every Biopsy

Doing More With Every Biopsy

• 

  Jillian Phallen, PhD

  Cancer genomics; liquid biopsy/ctDNA

  •

  Johns Hopkins Kimmel Cancer Center

  Noninvasive liquid biopsies identifying tumor-specific changes provide an opportunity for widespread implementation of monitoring approaches for different cancer types in a variety of clinical settings.

  Source
• 

  Pedram Razavi, MD, PhD

  Breast medical oncology; molecular oncology

  •

  Memorial Sloan Kettering Cancer Center

  Liquid biopsy can provide a more global picture of tumor mutations as all the tumor sites potentially contribute to the cfDNA pool in circulation.

  Source
• 

  George Vasmatzis, PhD

  Molecular pathology; biomarker discovery

  •

  Mayo Clinic

  With liquid biopsies, we don’t have to wait for tumor growth to get a DNA sample. This important discovery makes it possible for us to detect recurrence of the disease earlier than other diagnostic methods. We can repeat liquid biopsies to monitor the progression of the cancer. That gives hope of a better treatment plan over time.

  Source
• 

  Lisa Rimsza, MD

  Hematopathology; lymphoma diagnostics

  •

  Mayo Clinic

  We specialize in developing new tests to make sure we can get the most accurate diagnosis for the patient, and also figure out whether their disease is likely to be more or less aggressive.

  Source